Industrivarden AB operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Industrivarden AB with three other
financial institutions in Europe:
MedCap AB (publ)
sales of 851.67 million Swedish Kronor [US$106.91 million]
of which 37%
Gimv Investeringsmaatschappij Voor Vlanderen NV
(136.94 million Euro [US$170.33 million]
of which 41%
was Other), and
HBM Healthcare Investments AG
based in Switzerland
(178.50 million Swiss Francs [US$192.98 million]
During the year ended December of 2017, sales at
Industrivarden AB were SEK 2.79 billion (US$349.73 million).
decrease of 9.5%
versus 2016, when the company's sales were SEK 3.08 billion.